JAGSNPHARM

Jagsonpal Pharmaceuticals Limited

Pharmaceutical formulations and APIs for domestic and export markets

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

jagsonpal.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹218.37
Market cap
1,440 Cr
Stock P/E
31.7
P/B
5.29
Dividend yield
0.7%
ROE (FY26)
15.6%
ROCE (FY26)
21.2%
Operating margin (FY26)
16.9%
OCF / EBITDA (FY26)
80.6%
OCF / EBITDA (3Y)
103.8%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Jagsonpal Pharmaceuticals sells branded prescription medicines in India, mainly through a field force of about 1,000 medical representatives, and in 2026 bought into the hospital segment by acquiring Aequitas Healthcare.

Company snapshot

84thBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓104% of operating profit came in as cash over the last three years — profits are backed by real cash.
1 more signal from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales58 Cr47 Cr43 Cr61 Cr75 Cr74 Cr59 Cr76 Cr74 Cr73 Cr64 Cr82 Cr
Operating expenses (approx.)49 Cr44 Cr41 Cr51 Cr58 Cr58 Cr50 Cr61 Cr58 Cr57 Cr53 Cr65 Cr
EBITDA8 Cr3 Cr3 Cr10 Cr16 Cr16 Cr9 Cr14 Cr16 Cr16 Cr11 Cr17 Cr
OPM %14.5%7.2%6.1%16.7%21.8%21.4%14.9%18.8%22.1%22.3%17.4%21.0%
Other income2 Cr3 Cr2 Cr1 Cr2 Cr2 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr
Interest0.22 Cr0.23 Cr0.22 Cr0.21 Cr0.23 Cr0.26 Cr0.26 Cr0.25 Cr0.27 Cr0.26 Cr0.25 Cr0.25 Cr
Depreciation0.46 Cr0.41 Cr0.40 Cr1 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr
Profit before tax10 Cr5 Cr5 Cr7 Cr15 Cr39 Cr9 Cr14 Cr17 Cr15 Cr12 Cr18 Cr
Tax %25.0%24.9%21.8%25.0%25.4%17.3%24.4%25.2%25.2%24.6%25.5%25.4%
Net profit7 Cr4 Cr4 Cr5 Cr11 Cr32 Cr7 Cr11 Cr13 Cr11 Cr9 Cr13 Cr
EPS (₹)₹2.84₹1.48₹1.31₹1.94₹4.29₹4.74₹0.98₹1.60₹1.88₹1.67₹1.25₹2.00

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales146 Cr127 Cr167 Cr159 Cr188 Cr226 Cr237 Cr209 Cr269 Cr287 CrSign in free for the trailing twelve months
Operating expenses (approx.)127 Cr138 Cr157 Cr150 Cr169 Cr200 Cr203 Cr186 Cr218 Cr229 CrSign in free for the trailing twelve months
EBITDA19 Cr-11 Cr9 Cr9 Cr19 Cr26 Cr34 Cr23 Cr51 Cr58 CrSign in free for the trailing twelve months
OPM %13.1%-8.4%5.6%5.4%10.2%11.4%14.4%11.1%19.0%20.2%Sign in free for the trailing twelve months
Other income——1 Cr3 Cr4 Cr3 Cr6 Cr9 Cr8 Cr12 CrSign in free for the trailing twelve months
Interest3 Cr0.66 Cr0.75 Cr0.51 Cr0.51 Cr0.29 Cr0.41 Cr0.81 Cr0.96 Cr1 CrSign in free for the trailing twelve months
Depreciation2 Cr0.32 Cr1 Cr1 Cr1 Cr2 Cr1 Cr2 Cr8 Cr9 CrSign in free for the trailing twelve months
Profit before tax14 Cr-12 Cr9 Cr9 Cr22 Cr27 Cr35 Cr30 Cr70 Cr58 CrSign in free for the trailing twelve months
Tax %17.6%0.7%19.8%16.4%22.0%28.3%23.2%24.8%20.8%25.1%Sign in free for the trailing twelve months
Net profit12 Cr-12 Cr7 Cr8 Cr17 Cr20 Cr27 Cr22 Cr55 Cr43 CrSign in free for the trailing twelve months
EPS (₹)₹4.53₹-4.41₹2.75₹3.00₹6.51₹7.48₹10.20₹8.49₹8.26₹6.40Sign in free for the trailing twelve months
Dividend payout %————15.4%53.5%0.0%0.0%0.0%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital13 Cr13 Cr13 Cr13 Cr13 Cr13 Cr13 Cr13 Cr13 Cr13 Cr
Reserves97 Cr85 Cr91 Cr98 Cr109 Cr118 Cr146 Cr174 Cr227 Cr263 Cr
Borrowings8 Cr8 Cr4 Cr5 Cr7 Cr—————
Other liabilities25 Cr23 Cr28 Cr31 Cr35 Cr38 Cr36 Cr30 Cr38 Cr41 Cr
Total liabilities143 Cr130 Cr136 Cr147 Cr164 Cr168 Cr195 Cr217 Cr278 Cr317 Cr
Fixed assets (net)22 Cr21 Cr22 Cr22 Cr23 Cr22 Cr18 Cr0.91 Cr0.61 Cr0.57 Cr
CWIP—0.98 Cr2 Cr2 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Investments0.0005 Cr0.0005 Cr0.0005 Cr11 Cr12 Cr43 Cr1 Cr0 Cr0 Cr0 Cr
Loans & advances——0 Cr0 Cr0 Cr0.31 Cr0 Cr0 Cr0 Cr0 Cr
Inventories48 Cr51 Cr33 Cr29 Cr30 Cr30 Cr21 Cr15 Cr15 Cr15 Cr
Trade receivables39 Cr25 Cr21 Cr21 Cr13 Cr16 Cr21 Cr11 Cr13 Cr17 Cr
Cash & bank0.29 Cr0.52 Cr0.36 Cr0.28 Cr59 Cr26 Cr11 Cr13 Cr11 Cr10 Cr
Other assets34 Cr30 Cr58 Cr61 Cr27 Cr32 Cr123 Cr177 Cr238 Cr274 Cr
Total assets143 Cr130 Cr136 Cr147 Cr164 Cr168 Cr195 Cr217 Cr278 Cr317 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity-3 Cr-2 Cr31 Cr11 Cr28 Cr6 Cr40 Cr35 Cr55 Cr47 Cr
Cash from investing41 Cr-3 Cr-0.83 Cr-11 Cr-2 Cr-26 Cr-52 Cr-25 Cr-45 Cr-36 Cr
Cash from financing-34 Cr-0.60 Cr-6 Cr-0.94 Cr-7 Cr-12 Cr0 Cr-9 Cr-12 Cr-12 Cr
Net cash flow5 Cr-6 Cr24 Cr-0.46 Cr19 Cr-33 Cr-11 Cr2 Cr-2 Cr-0.99 Cr
Free cash flow (OCF − Capex)-6 Cr-5 Cr29 Cr9 Cr28 Cr5 Cr40 Cr35 Cr55 Cr47 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %14.5%-10.3%9.0%8.6%17.4%21.1%22.2%16.4%29.5%21.2%
ROE %10.8%-11.8%6.9%7.1%14.0%15.0%16.8%12.0%23.1%15.6%
Debtor days99724549252532191822
Inventory days322696307291280268241248302331
Days payable61123111116170147191125193262
Cash conversion cycle3606452412241351468214112691
OCF / EBITDA %-17.0%—331.0%131.8%147.9%21.7%117.6%152.5%108.3%80.6%
OCF / EBITDA % (3 years)——147.2%n.m.190.5%84.4%93.6%97.5%120.6%103.8%
Debt / equity0.070.080.040.040.06—0.000.000.00—
Current ratio3.743.313.462.892.983.245.9710.426.225.06
Net debt / EBITDA0.40—0.370.51-2.73-1.01-0.32-0.55-0.22-0.17